Ubs Group Ag Codexis, Inc. Transaction History

Ubs Group Ag

$528 Billion
Q1 2025

A detailed history of Ubs Group Ag transactions in Codexis, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 291,985 shares of CDXS stock, worth $712,443. This represents 0.0% of its overall portfolio holdings.

Number of Shares

291,985

Previous 53,186 448.99%

Holding current value

$712,443

Previous $253,000 210.28%

% of portfolio

0.0%

Previous 0.0%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$2.53 - $5.43 $604,161 - $1.3 Million	238,799 Added 448.99%	291,985 $785,000
Q4 2024 Feb 14, 2025	BUY	$2.91 - $5.81 $43,196 - $86,243	14,844 Added 38.71%	53,186 $253,000
Q3 2024 Nov 14, 2024	BUY	$2.62 - $3.71 $43,934 - $62,212	16,769 Added 77.73%	38,342 $118,000
Q2 2024 Aug 13, 2024	SELL	$2.65 - $3.92 $137,156 - $202,887	-51,757 Reduced 70.58%	21,573 $66,000
Q1 2024 May 13, 2024	BUY	$2.59 - $4.65 $8,764 - $15,735	3,384 Added 4.84%	73,330 $255,000
Q4 2023 Feb 09, 2024	BUY	$1.54 - $3.37 $82,571 - $180,692	53,618 Added 328.38%	69,946 $213,000
Q3 2023 Nov 09, 2023	SELL	$1.5 - $3.75 $59,271 - $148,177	-39,514 Reduced 70.76%	16,328 $30,000
Q2 2023 Aug 11, 2023	BUY	$2.21 - $4.43 $40,602 - $81,387	18,372 Added 49.03%	55,842 $156,000
Q1 2023 May 12, 2023	SELL	$3.81 - $6.76 $50,551 - $89,691	-13,268 Reduced 26.15%	37,470 $155,000
Q4 2022 Feb 08, 2023	BUY	$4.26 - $6.84 $162,254 - $260,521	38,088 Added 301.09%	50,738 $236,000
Q3 2022 Nov 10, 2022	BUY	$6.06 - $12.86 $70,805 - $150,256	11,684 Added 1209.52%	12,650 $76,000
Q2 2022 Aug 10, 2022	SELL	$8.35 - $21.89 $551 - $1,444	-66 Reduced 6.4%	966 $10,000
Q1 2022 May 16, 2022	SELL	$16.97 - $31.93 $20,482 - $38,539	-1,207 Reduced 53.91%	1,032 $21,000
Q4 2021 Feb 14, 2022	BUY	$25.61 - $41.78 $29,912 - $48,799	1,168 Added 109.06%	2,239 $70,000
Q3 2021 Nov 15, 2021	SELL	$19.65 - $27.99 $46,374 - $66,056	-2,360 Reduced 68.78%	1,071 $25,000
Q2 2021 Aug 13, 2021	SELL	$17.48 - $25.46 $184,239 - $268,348	-10,540 Reduced 75.44%	3,431 $78,000
Q1 2021 May 12, 2021	BUY	$18.08 - $28.8 $115,892 - $184,608	6,410 Added 84.78%	13,971 $320,000
Q4 2020 Feb 11, 2021	SELL	$11.7 - $23.41 $41,371 - $82,777	-3,536 Reduced 31.86%	7,561 $166,000
Q3 2020 Nov 12, 2020	SELL	$11.21 - $13.82 $183,305 - $225,984	-16,352 Reduced 59.57%	11,097 $131,000
Q2 2020 Jul 31, 2020	SELL	$9.8 - $12.77 $81,810 - $106,603	-8,348 Reduced 23.32%	27,449 $313,000
Q1 2020 May 01, 2020	SELL	$8.78 - $18.6 $534,605 - $1.13 Million	-60,889 Reduced 62.98%	35,797 $400,000
Q4 2019 Feb 14, 2020	BUY	$13.12 - $17.06 $393,101 - $511,151	29,962 Added 44.9%	96,686 $1.55 Million
Q3 2019 Nov 14, 2019	BUY	$12.75 - $19.01 $364,331 - $543,210	28,575 Added 74.9%	66,724 $915,000
Q2 2019 Aug 14, 2019	BUY	$17.0 - $21.88 $134,623 - $173,267	7,919 Added 26.2%	38,149 $703,000
Q1 2019 May 14, 2019	SELL	$15.53 - $22.15 $333,258 - $475,316	-21,459 Reduced 41.52%	30,230 $621,000
Q4 2018 Feb 14, 2019	BUY	$14.06 - $22.57 $77,470 - $124,360	5,510 Added 11.93%	51,689 $863,000
Q3 2018 Nov 14, 2018	BUY	$13.35 - $19.1 $195,550 - $279,776	14,648 Added 46.46%	46,179 $792,000
Q2 2018 Aug 14, 2018	SELL	$10.35 - $16.45 $31,702 - $50,386	-3,063 Reduced 8.85%	31,531 $454,000
Q1 2018 May 15, 2018	BUY	$8.0 - $12.8 $29,744 - $47,590	3,718 Added 12.04%	34,594 $381,000
Q4 2017 Feb 14, 2018	BUY	$5.85 - $8.4 $27,799 - $39,916	4,752 Added 18.19%	30,876 $258,000
Q3 2017 Nov 14, 2017	SELL	$4.9 - $6.65 $21,016 - $28,521	-4,289 Reduced 14.1%	26,124 $174,000
Q2 2017 Aug 14, 2017	BUY	N/A	28,553 Added 1535.11%	30,413 $166,000
Q1 2017 Nov 14, 2017	BUY	N/A	1,860	1,860 $9,000

Others Institutions Holding CDXS

# of Institutions

139

Shares Held

63.7M

Call Options Held

37.7K

Put Options Held

25.9K

View Full List

About CODEXIS, INC.

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $160M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

More about CDXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account